Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse M Cedarbaum

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
NPJ Parkinson'S Disease|October 21, 2022
Neuromelanin and T<sub>2</sub>*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's diseaseDafna Ben Bashat, Avner Thaler, Hedva Lerman Shacham, et al.
Scientific Reports|June 11, 2020
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's diseaseAvner Thaler, Shani Shenhar-Tsarfaty, Yanay Shaked, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiographySyed Mahmood Shah, Sinan Tatlipinar, Edward Quinlan, et al.
Molecular Genetics and Metabolism|October 31, 2019
Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?Orly Goldstein, Mali Gana-Weisz, Danielle Cohen-Avinoam, et al.
Journal of Parkinson'S Disease|May 17, 2021
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory MarkersAvner Thaler, Nurit Omer, Nir Giladi, et al.
The American Journal of Gastroenterology|June 24, 2003
Neurotrophin-3 improves functional constipationHenry P Parkman, Satish S C Rao, James C Reynolds, et al.
NPJ Parkinson'S Disease|March 4, 2022
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersAmgad Droby, Moran Artzi, Hedva Lerman, et al.
Digital Biomarkers|March 17, 2020
Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical ResearchReham Badawy, Farhan Hameed, Lauren Bataille, et al.
Parkinsonism & Related Disorders|May 1, 2024
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's diseaseAvner Thaler, Vered Livne, Einat Rubinstein, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|May 18, 2012
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosisJeremy Shefner, Jesse M Cedarbaum, Merit E Cudkowicz, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
NPJ Parkinson'S Disease|October 21, 2022
Neuromelanin and T<sub>2</sub>*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's diseaseDafna Ben Bashat, Avner Thaler, Hedva Lerman Shacham, et al.
Scientific Reports|June 11, 2020
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's diseaseAvner Thaler, Shani Shenhar-Tsarfaty, Yanay Shaked, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiographySyed Mahmood Shah, Sinan Tatlipinar, Edward Quinlan, et al.
Molecular Genetics and Metabolism|October 31, 2019
Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?Orly Goldstein, Mali Gana-Weisz, Danielle Cohen-Avinoam, et al.
Journal of Parkinson'S Disease|May 17, 2021
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory MarkersAvner Thaler, Nurit Omer, Nir Giladi, et al.
The American Journal of Gastroenterology|June 24, 2003
Neurotrophin-3 improves functional constipationHenry P Parkman, Satish S C Rao, James C Reynolds, et al.
NPJ Parkinson'S Disease|March 4, 2022
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersAmgad Droby, Moran Artzi, Hedva Lerman, et al.
Digital Biomarkers|March 17, 2020
Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical ResearchReham Badawy, Farhan Hameed, Lauren Bataille, et al.
Parkinsonism & Related Disorders|May 1, 2024
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's diseaseAvner Thaler, Vered Livne, Einat Rubinstein, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|May 18, 2012
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosisJeremy Shefner, Jesse M Cedarbaum, Merit E Cudkowicz, et al.
Pageof 8